Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03696784
Title Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

nodal marginal zone lymphoma

B-cell lymphoma

primary mediastinal B-cell lymphoma

splenic marginal zone lymphoma

MALT lymphoma

mantle cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Rimiducid

Bendamustine + Fludarabine + iC9-CAR.19-IL15-Transduced CB-NK

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill North Carolina 27599 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field